Skip to main content

Month: January 2026

Duke Robotics Announces $750,000 Private Placement at a Premium to Market

Premium-Priced Financing with Participation from Long-Time Investors Strengthens Balance Sheet and is Expected to Support Near-Term Execution Opportunities the Company is Targeting Fort Lauderdale, FL, Jan. 05, 2026 (GLOBE NEWSWIRE) — Duke Robotics Corp. (OTCQB: DUKR) (“Duke Robotics” or the “Company”), a leader in advanced robotics technology and autonomous drone solutions for the civilian and defense markets, today announced that on December 30, 2025, it entered into definitive securities purchase agreements (the “Securities Purchase Agreements”) with a group of accredited investors in a private placement raising gross proceeds of $750,000. The private placement included participation from existing long-time investors of the Company. The Company intends to use the net proceeds from the private placement...

Continue reading

Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary

January 05, 2026 Biodexa Pharmaceuticals PLC Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, is delighted to announce the promotion of Fiona Sharp to Chief Financial Officer and Company Secretary along with her election to the Board of Directors of the Company with immediate effect. Ms Sharp is a senior finance professional having joined the Company as Group Financial Controller in December 2019. During her tenure, she has consistently broadened her remit to include many of the responsibilities of a CFO. Before joining Biodexa Ms Sharp was Assistant Director of Finance for the Hywel...

Continue reading

“Surviving Barstool” Season 5 Uncensored – Exclusive Episode Access Window on Rumble Premium

LONGBOAT KEY, FL, Jan. 05, 2026 (GLOBE NEWSWIRE) — Rumble Inc. (NASDAQ:RUM), the Freedom-First technology platform, today announced that each episode of the highly anticipated 5th season of “Surviving Barstool” will stream on Rumble Premium for an exclusive window before the episode is available anywhere else. New episodes are scheduled for 2026 on dates and times yet to be determined by Barstool. “Surviving Barstool” follows a group of well-known Barstool employees competing against each other for a large cash prize while trapped in the office. The final winner will be decided by the employees who were voted out along the way. “Barstool continues to be one of the best, fastest-growing sports and entertainment brands on the internet, so it’s natural for us at Rumble to partner with them,” said Rumble CEO Chris Pavlovski. “We’ve...

Continue reading

Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 13, 2026 at 2:15 p.m. PT / 5:15 p.m. ET. A live webcast of the presentation can be accessed by visiting “Investor Events” on the Investors section of the Wave Life Sciences website: https://ir.wavelifesciences.com/events-publications/events. A replay of this presentation will be archived and available on the site for a limited time following the event. About Wave Life SciencesWave Life Sciences (Nasdaq: WVE) is a biotechnology...

Continue reading

Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference

VANCOUVER, British Columbia and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced that the company will present at the 44th Annual J.P. Morgan Healthcare Conference, taking place in San Francisco, CA from January 12-15, 2026. Company Presentation Details:Date: Monday, January 12, 2026   Time: 9:00-9:40am Pacific Time (12:00-12:40pm Eastern Time)   Webcast: Webcast – 44th Annual J.P. Morgan Healthcare Conference   Presenter: Ian Mortimer, President and Chief Executive Officer, Xenon Pharmaceuticals   A live audio webcast of the company presentation will be available on the Investors...

Continue reading

Ascendis Pharma to Participate in the 44th Annual J.P. Morgan Healthcare Conference

COPENHAGEN, Denmark, Jan. 05, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in the 44th Annual J.P. Morgan Healthcare Conference and provide a business update on Monday, January 12, 2026, at 10:30 a.m. Eastern Time / 7:30 a.m. Pacific Time in San Francisco, California. A live webcast of the presentation will be available via the Investors & News section of the Ascendis Pharma website at investors.ascendispharma.com. A webcast replay will also be available on this website shortly after conclusion of the event for 30 days. About Ascendis Pharma A/SAscendis Pharma is a global biopharmaceutical company focused on applying our innovative TransCon technology platform to make a meaningful difference for patients. Guided by our core values of Patients, Science,...

Continue reading

rYojbaba Issues Letter to Shareholders Detailing 2025 Operational Highlights and 2026 Strategic Priorities

FUKUOKA, Japan, Jan. 05, 2026 (GLOBE NEWSWIRE) — rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or the “Company”), a Japanese labor consulting and health services company, today issued a letter to its shareholders addressing recent operational highlights and future business initiatives and growth strategies. From the Founder and Chief Executive Officer, Ryoji Baba Dear Shareholders, First and foremost, we would like to extend our heartfelt gratitude to all our shareholders and stakeholders who have supported rYojbaba throughout our journey. The successful public listing on August 14, 2025 marked a defining corporate milestone and is one that could not have been achieved without the continued support of our employees, partners, clients, and now, you, our shareholders. From the start of the year and since the successful listing, we’ve...

Continue reading

Reliance Global Group Authorizes the Formation of EZRA International Group, a New Division Focused on Accelerating Breakthrough Technology Companies

LAKEWOOD, NJ, Jan. 05, 2026 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI) (the “Company”) today announced the unanimous Board approval for its formation of EZRA International Group, a new division focused on acquiring controlling stakes and accelerating growth of high-tech Israeli companies, with an initial focus on the Cybersecurity, AI & Data Analytics, FinTech & InsurTech, as well as MedTech & Digital Health sectors. Through this initiative, the Company intends to pursue a structured path toward value realization, which may include public listings, strategic spin-offs, or other monetization events designed to maximize shareholder value. “We believe the current market capitalization of the Company does not fully reflect the intrinsic value and historic cash flow of our insurance operations,” said...

Continue reading

Grayscale Ethereum Staking ETF (Ticker: ETHE) Becomes First U.S. Ethereum ETP to Distribute Staking Rewards

Shares of Grayscale Ethereum Staking ETF set to trade ex-Dividend at Today’s Market Open STAMFORD, Conn., Jan. 05, 2026 (GLOBE NEWSWIRE) — Grayscale, the world’s largest digital asset-focused investment platform*, today announced that Grayscale Ethereum Staking ETF (Ticker: ETHE) has made a distribution to existing shareholders of proceeds from the sale of staking rewards earned by the Fund between October 6, 2025 and December 31, 2025. The milestone marks the first time a spot crypto ETP in the U.S. has distributed staking rewards to shareholders. As a result of this distribution, shareholders of ETHE will receive $0.083178 per share held, reflecting the proceeds from the Fund’s sale of staking rewards earned during the applicable period. The payout will be made to investors on the payable date, January 6, 2026, based on...

Continue reading

Jeffs’ Brands: KeepZone AI Expands its Homeland Security Portfolio with Entry into Representation Agreement for RT LTA Systems’sAdvanced Aerostat Systems

Tel Aviv, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace expanding into the global homeland security sector through advanced artificial intelligence (“AI”)-driven solutions, today announced that its wholly owned subsidiary, KeepZone AI Inc., (“KeepZone”), has entered into a representation agreement (the “Agreement”) with RT LTA Systems Ltd. (“RT”), an Israeli designer, developer, and manufacturer of the SkyStar™ family of aerostats. Under the Agreement, KeepZone will promote and facilitate sales of RT’s advanced aerostat systems in defined territories for an initial term of six months. RT’s SkyStarTM aerostat family of combat-proven, compact and mobile intelligence, surveillance,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.